Prevalence of medical contraindications to nirmatrelvir/ritonavir in a cohort of hospitalized and non-hospitalized patients with COVID-19
Open forum infectious diseases
; 2022.
Article
in English
| EuropePMC | ID: covidwho-1999020
ABSTRACT
This analysis describes the prevalence of contraindications to nirmatrelvir/ritonavir among 66,007 patients with COVID-19 in a large health care system. A possible contradiction was present in 9,830 patients (14.8%), with the prevalence of contraindications increasing with higher acuity of illness.
Search on Google
Collection:
Databases of international organizations
Database:
EuropePMC
Type of study:
Cohort study
/
Observational study
/
Prognostic study
Language:
English
Journal:
Open forum infectious diseases
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS